Condition
Amyotrophic Lateral Sclerosis, Sporadic
Total Trials
4
Recruiting
0
Active
1
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
1Total
P 2 (1)
Trial Status
Suspended1
Completed1
Withdrawn1
Active Not Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT05928416Active Not RecruitingPrimary
ALS Diagnosis From a Saliva Sample: a Non-coding RNA Analysis Approach
NCT01459302Withdrawn
Genetic Study of Familial and Sporadic ALS/Motor Neuron Disease, Miyoshi Myopathy and Other Neuromuscular Disorders
NCT03449212Suspended
SOD1 Kinetics Measurements in ALS Patients
NCT03204500Phase 2Completed
Dual Treatment With Lithium and Valproate in ALS.
Showing all 4 trials